{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:31:41Z","timestamp":1787315501035,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>The catechol-O-methyltransferase enzyme catalyzes the methylation of the catechol estrogens, 2- or 4-hydroxyestrogen, to 2- or 4-methoxyestrogen. Both the hydroxy estrogens and methoxy estrogens were shown to modulate the effects of estrogen. Because catechol-O-methyltransferase activity controls levels of these metabolites, it may help regulate the cellular estrogenic milieu. In this study, we examined the regulation of catechol-O-methyltransferase expression in human myometrial cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Catechol-O-methyltransferase expression was assessed by reverse transcription\u2013polymerase chain reaction, Western blot, and luciferase assays in human myometrial cells after treatment with estrogen or progesterone. Catechol-O-methyltransferase expression was measured in cells after treatment with tumor necrosis factor alpha (TNF\u03b1) alone or with lactacystin, a proteasome inhibitor. Luciferase assays were also conducted using human myometrial cells containing an estrogen response element\u2013luciferase reporter gene to measure levels of estrogen-mediated transactivation after treatment with estrogen and increasing concentrations of 2-hydroxestrogen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Catechol-O-methyltransferase expression was down-regulated by progesterone or estrogen. Tumor necrosis factor alpha upregulated catechol-O-methyltransferase expression, whereas cotreatment with lactacystin attenuated this response, suggesting that TNF\u03b1 activated nuclear factor kappa B to induce catechol-O-methyltransferase expression. Increased concentrations of 2-hydroxyestrogen attenuated estrogen-mediated transcription in the myometrial cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Catechol-O-methyltransferase expression may be regulated in the myometrium to control the local action of estrogen. Low levels of catechol-O-methyltransferase in the myometrium would result in an accumulation of 2-hydroxyestrogen and may antagonize the local effect of estrogen. High levels of catechol-O-methyltransferase in the myometrium would result in lower levels of 2-hydroxyestrogen and may increase sensitivity to estrogen.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/01.aog.0000243775.73788.11","type":"journal-article","created":{"date-parts":[[2010,11,15]],"date-time":"2010-11-15T10:26:02Z","timestamp":1289816762000},"page":"1439-1447","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Regulation of Catechol-O-Methyltransferase Expression in Human Myometrial Cells"],"prefix":"10.1097","volume":"108","author":[{"given":"Melissa J.","family":"Wentz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Jamaluddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Garfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20260821","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0021-9258(18)64731-3","article-title":"Enzymatic O-methylation of epinephrine and other catechols.","volume":"233","author":"Axelrod","year":"1958","journal-title":"J Biol Chem"},{"key":"R2-16-20260821","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1023680302975","article-title":"The role of catechol-O-methyltransferase in the inactivation of catecholestrogen.","volume":"23","author":"Creveling","year":"2003","journal-title":"Cell Mol Neurobiol"},{"key":"R3-16-20260821","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0303-7207(89)90135-4","article-title":"Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation.","volume":"61","author":"Vandewalle","year":"1989","journal-title":"Mol Cell Endocrinol"},{"key":"R4-16-20260821","doi-asserted-by":"crossref","first-page":"S259","DOI":"10.1677\/joe.0.150S259","article-title":"2-Hydroxyesterone: the \u201cgood\u201d estrogen.","volume":"150","author":"Bradlow","year":"1996","journal-title":"J Endocrinol"},{"key":"R5-16-20260821","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jsgi.2005.10.007","article-title":"Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups.","volume":"13","author":"Al-Hendy","year":"2006","journal-title":"J Soc Gynecol Investig"},{"key":"R6-16-20260821","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1476-5586(03)80044-1","article-title":"2-Methoxyestradiol exhibits a biphasic effect on VEGF-A in tumor cells and upregulation is mediated through ER-alpha: a possible signaling pathway associated with the impact of 2-ME2 on proliferative cells.","volume":"5","author":"Banerjee","year":"2003","journal-title":"Neoplasia"},{"key":"R7-16-20260821","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0024-3205(02)02305-6","article-title":"The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells.","volume":"72","author":"Lippert","year":"2003","journal-title":"Life Sci"},{"key":"R8-16-20260821","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jsbmb.2003.12.003","article-title":"Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.","volume":"88","author":"Liu","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R9-16-20260821","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/1078-0432.CCR-04-1789","article-title":"2-methoxyestradiol is an estrogen receptor agonist that supports tumor growth in murine xenograft models of breast cancer.","volume":"11","author":"Sutherland","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R10-16-20260821","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/00016347409156887","article-title":"The simultaneous function of catechol-O-methyltransferase and monoamine oxidase in human placenta.","volume":"53","author":"Castren","year":"1974","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R11-16-20260821","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2007-999669","article-title":"Catechol-o-methyl transferase activity in the human term placenta.","volume":"5","author":"Barnea","year":"1988","journal-title":"Am J Perinatol"},{"key":"R12-16-20260821","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0002-9378(83)90316-2","article-title":"Characterization of catechol-O-methyltransferase activity in human uterine decidua vera tissue.","volume":"145","author":"Casey","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"R13-16-20260821","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF01926474","article-title":"Hormonal influences on erythrocyte catechol-O-methyl transferase activity in humans.","volume":"29","author":"Briggs","year":"1973","journal-title":"Experientia"},{"key":"R14-16-20260821","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1476-5381.1976.tb07682.x","article-title":"Decreased phenylethanolamine-N-methyltransferase and catechol-O-methyltransferase activity in rabbit adrenal glands during pregnancy.","volume":"57","author":"Parvez","year":"1976","journal-title":"Br J Pharmacol"},{"key":"R15-16-20260821","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/39.6.2033240","article-title":"Induction of catechol-O-methyltransferase in the luminal epithelium of rat uterus by progesterone.","volume":"39","author":"Inoue","year":"1991","journal-title":"J Histochem Cytochem"},{"key":"R16-16-20260821","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/mol.56.1.31","article-title":"Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription.","volume":"56","author":"Xie","year":"1999","journal-title":"Mol Pharmacol"},{"key":"R17-16-20260821","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0002-9378(95)90284-8","article-title":"Mitogenic effect of basic fibroblast growth factor and estradiol on cultured human myometrial and leiomyoma cells.","volume":"173","author":"Rauk","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R18-16-20260821","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.ajog.2004.04.022","article-title":"Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice.","volume":"191","author":"Al-Hendy","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R19-16-20260821","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/molehr\/gah086","article-title":"Immortalization and characterization of human myometrial cells from term-pregnant patients using a telomerase expression vector.","volume":"10","author":"Soloff","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"R20-16-20260821","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1210\/endo.142.9.8372","article-title":"Dominant negative ER induces apoptosis in GH(4) pituitary lactotrope cells and inhibits tumor growth in nude mice.","volume":"142","author":"Lee","year":"2001","journal-title":"Endocrinology"},{"key":"R21-16-20260821","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal Biochem"},{"key":"R22-16-20260821","article-title":"Molecular cloning: a laboratory manual. 2nd ed.","author":"Sambrook","year":"1989"},{"key":"R23-16-20260821","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1210\/jcem-41-4-744","article-title":"Excretion of 2-hydroxyestrone in urine throughout human pregnancies.","volume":"41","author":"Gelbke","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-16-20260821","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1210\/jcem-22-2-134","article-title":"Observations on the occurrence of six estrogen fractions in human pregnancy urine. I. Normal pregnancy.","volume":"22","author":"Hobkirk","year":"1962","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-16-20260821","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1210\/jcem-23-3-274","article-title":"2-methoxyestrone as an estrogen metabolite in the human subject.","volume":"23","author":"Hobkirk","year":"1963","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-16-20260821","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/phgs.5.1.57.25687","article-title":"Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology.","volume":"5","author":"Tempfer","year":"2004","journal-title":"Pharmacogenomics"},{"key":"R27-16-20260821","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00008571-199606000-00007","article-title":"Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.","volume":"6","author":"Lachman","year":"1996","journal-title":"Pharmacogenetics"},{"key":"R28-16-20260821","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-3016.2002.00394.x","article-title":"Changing patterns of low birthweight and preterm birth in the United States, 1981\u201398.","volume":"16","author":"Branum","year":"2002","journal-title":"Paediatr Perinat Epidemiol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-200612000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:01:00Z","timestamp":1787313660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-200612000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aog.0000243775.73788.11","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}